scholarly article | Q13442814 |
P50 | author | Peter Sporn | Q68038814 |
P2093 | author name string | Alan R Hauser | |
Jacob I Sznajder | |||
Lynn C Welch | |||
Heather A Howell | |||
Greg J Beitel | |||
Khalilah L Gates | |||
Aisha Nair | |||
Christine U Vohwinkel | |||
P2860 | cites work | Hypercapnic acidosis is protective in an in vivo model of ventilator-induced lung injury. | Q51708605 |
Mortality of COPD Patients Infected with Multi-Resistant Pseudomonas aeruginosa: A Case and Control Study | Q61766695 | ||
Defective Phagocytosis and Clearance of Pseudomonas aeruginosa in the Lung Following Bone Marrow Transplantation | Q61942141 | ||
Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection | Q68028746 | ||
Guidelines for the welfare of animals in rodent protection tests. A report from the Rodent Protection Test Working Party | Q72365952 | ||
Pseudomonas aeruginosa keratitis in IL-6-deficient mice | Q73209330 | ||
Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-al | Q73501417 | ||
Protective effects of hypercapnic acidosis on ventilator-induced lung injury | Q74493910 | ||
Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation | Q80469703 | ||
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study | Q83704959 | ||
Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease | Q87410890 | ||
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia | Q22241905 | ||
Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation | Q22306317 | ||
Pseudomonas aeruginosa gene products PilT and PilU are required for cytotoxicity in vitro and virulence in a mouse model of acute pneumonia | Q28492676 | ||
Neutrophils and immunity: challenges and opportunities | Q29617616 | ||
Lung infections associated with cystic fibrosis | Q30080000 | ||
Pseudomonas aeruginosa induces localized immunosuppression during pneumonia | Q30483670 | ||
Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit | Q30828471 | ||
Elevated CO2 selectively inhibits interleukin-6 and tumor necrosis factor expression and decreases phagocytosis in the macrophage | Q33919428 | ||
Evolutionary conserved role of c-Jun-N-terminal kinase in CO2-induced epithelial dysfunction | Q34441889 | ||
Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome | Q34454558 | ||
Severe hypercapnia in critically ill adult cystic fibrosis patients | Q35756954 | ||
Pulmonary bacterial communities in surgically resected noncystic fibrosis bronchiectasis lungs are similar to those in cystic fibrosis. | Q35788879 | ||
Etiology of ventilator-associated pneumonia. | Q36085175 | ||
Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia | Q36388035 | ||
Mortality in COPD: Role of comorbidities. | Q36670236 | ||
Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease | Q37103705 | ||
Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells | Q37137636 | ||
Lung NF-kappaB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia | Q37297010 | ||
Elevated CO2 suppresses specific Drosophila innate immune responses and resistance to bacterial infection | Q37413464 | ||
Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia | Q37451128 | ||
Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. | Q39826884 | ||
Assessing PaCO2 in acute respiratory disease: accuracy of a transcutaneous carbon dioxide device. | Q40364242 | ||
Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease | Q40393573 | ||
Permissive hypercapnic ventilation | Q40704038 | ||
Infection-induced lung injury is worsened after renal buffering of hypercapnic acidosis. | Q43272791 | ||
Sustained hypercapnic acidosis during pulmonary infection increases bacterial load and worsens lung injury | Q43792215 | ||
Predicting survival following non-invasive ventilation for hypercapnic exacerbations of chronic obstructive pulmonary disease. | Q43970344 | ||
Hypercapnic acidosis attenuates endotoxin-induced acute lung injury | Q44575154 | ||
Hypercapnic acidosis attenuates lung injury induced by established bacterial pneumonia | Q46301623 | ||
Effect of CO2 on LPS-induced cytokine responses in rat alveolar macrophages | Q46390953 | ||
Hypercapnic acidosis does not modulate the severity of bacterial pneumonia-induced lung injury | Q46795294 | ||
NF-κB links CO2 sensing to innate immunity and inflammation in mammalian cells | Q47363631 | ||
Hypercapnic acidosis and mortality in acute lung injury | Q47664201 | ||
Arterial carbon dioxide tension on admission as a marker of in-hospital mortality in community-acquired pneumonia | Q47853384 | ||
Hypercapnic acidosis attenuates severe acute bacterial pneumonia-induced lung injury by a neutrophil-independent mechanism | Q48468347 | ||
Death in the United States, 2009. | Q51379462 | ||
P433 | issue | 5 | |
P921 | main subject | pneumonia | Q12192 |
hypercapnia | Q615759 | ||
P304 | page(s) | 821-828 | |
P577 | publication date | 2013-11-01 | |
P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
P1476 | title | Hypercapnia impairs lung neutrophil function and increases mortality in murine pseudomonas pneumonia | |
P478 | volume | 49 |
Q50192420 | A role for heat shock factor 1 in hypercapnia-induced inhibition of inflammatory cytokine expression |
Q47771741 | Association Between Partial Pressure of Arterial Carbon Dioxide and Survival to Hospital Discharge Among Patients Diagnosed With Sepsis in the Emergency Department |
Q41572208 | Association of hypercapnia on admission with increased length of hospital stay and severity in patients admitted with community-acquired pneumonia: a prospective observational study from Pakistan |
Q97598048 | Carbon dioxide as a drug in neonatology |
Q40211722 | Carbon dioxide-dependent regulation of NF-κB family members RelB and p100 gives molecular insight into CO2-dependent immune regulation. |
Q37623230 | Carbon dioxide-sensing in organisms and its implications for human disease. |
Q39241653 | Determinants of hypoxia inducible factor (HIF) activity in the intestinal mucosa |
Q58701988 | Driving-pressure-independent protective effects of open lung approach against experimental acute respiratory distress syndrome |
Q35906092 | Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory |
Q38376558 | Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial |
Q23911485 | Effect of elevated carbon dioxide on bronchial epithelial innate immune receptor response to organic dust from swine confinement barns |
Q49870420 | Effects of hypercapnia in acute respiratory distress syndrome |
Q39065369 | Effects of hypercapnia on the lung |
Q91657014 | Elevated CO2 regulates the Wnt signaling pathway in mammals, Drosophila melanogaster and Caenorhabditis elegans |
Q38809312 | Focused Screening Identifies Evoxine as a Small Molecule That Counteracts CO2-Induced Immune Suppression |
Q35580888 | High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1). |
Q38725991 | Hypercapnia Accelerates Adipogenesis: A Novel Role of High CO2 in Exacerbating Obesity |
Q58756398 | Hypercapnia Alters Expression of Immune Response, Nucleosome Assembly and Lipid Metabolism Genes in Differentiated Human Bronchial Epithelial Cells |
Q38701042 | Hypercapnia Impairs ENaC Cell Surface Stability by Promoting Phosphorylation, Polyubiquitination and Endocytosis of β-ENaC in a Human Alveolar Epithelial Cell Line |
Q89878721 | Hypercapnia Impairs Na,K-ATPase Function by Inducing Endoplasmic Reticulum Retention of the β-Subunit of the Enzyme in Alveolar Epithelial Cells |
Q35613035 | Hypercapnia Inhibits Autophagy and Bacterial Killing in Human Macrophages by Increasing Expression of Bcl-2 and Bcl-xL. |
Q36941109 | Hypercapnia Suppresses the HIF-dependent Adaptive Response to Hypoxia |
Q55032250 | Hypercapnic acidosis attenuates pressure-dependent increase in whole-lung filtration coefficient (Kf). |
Q38772023 | Hypoxia and cellular metabolism in tumour pathophysiology |
Q40880372 | Identification of Drosophila Zfh2 as a Mediator of Hypercapnic Immune Regulation by a Genome-Wide RNA Interference Screen. |
Q92219703 | Mechanism of benefit of non-invasive ventilation in COPD with hypercapnic respiratory failure |
Q35883509 | Moderately high frequency ventilation with a conventional ventilator allows reduction of tidal volume without increasing mean airway pressure |
Q48017846 | Parabiotic model for differentiating local and systemic effects of continuous and intermittent hypoxia |
Q36410364 | Permissive hypercapnia for severe acute respiratory distress syndrome in immunocompromised children: A single center experience. |
Q42367554 | Physiologic effects of alveolar recruitment and inspiratory pauses during moderately-high-frequency ventilation delivered by a conventional ventilator in a severe lung injury model. |
Q92048394 | Pre-Treatment with Ten-Minute Carbon Dioxide Inhalation Prevents Lipopolysaccharide-Induced Lung Injury in Mice via Down-Regulation of Toll-Like Receptor 4 Expression |
Q39170072 | Prognostic value of on admission arterial PCO2 in hospitalized patients with community-acquired pneumonia. |
Q41121851 | Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study |
Q38382095 | Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome |
Q37676196 | Sleep apnea and risk of pneumonia: a nationwide population-based study |
Q27314666 | The response to high CO2 levels requires the neuropeptide secretion component HID-1 to promote pumping inhibition |
Q91910695 | [Veno-venous extracorporeal support to treat acute respiratory distress syndrome: Rationale and clinical objectives] |
Search more.